JPH11263727A - Minoxidil formulated liquid preparation composition - Google Patents
Minoxidil formulated liquid preparation compositionInfo
- Publication number
- JPH11263727A JPH11263727A JP10342699A JP34269998A JPH11263727A JP H11263727 A JPH11263727 A JP H11263727A JP 10342699 A JP10342699 A JP 10342699A JP 34269998 A JP34269998 A JP 34269998A JP H11263727 A JPH11263727 A JP H11263727A
- Authority
- JP
- Japan
- Prior art keywords
- minoxidil
- amino acid
- liquid preparation
- liquid composition
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 39
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 title claims abstract description 26
- 229960003632 minoxidil Drugs 0.000 title claims abstract description 26
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 150000001413 amino acids Chemical class 0.000 claims abstract description 24
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 17
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000004040 coloring Methods 0.000 claims abstract description 11
- 229960003080 taurine Drugs 0.000 claims abstract description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000002904 solvent Substances 0.000 claims abstract description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 claims abstract description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 claims abstract description 3
- 239000011593 sulfur Substances 0.000 claims abstract description 3
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 238000013329 compounding Methods 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 abstract description 17
- -1 polyethylene Polymers 0.000 abstract description 5
- 239000008213 purified water Substances 0.000 abstract description 5
- 239000011521 glass Substances 0.000 abstract description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 abstract description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract description 2
- 239000004698 Polyethylene Substances 0.000 abstract description 2
- 239000004743 Polypropylene Substances 0.000 abstract description 2
- 150000001298 alcohols Chemical class 0.000 abstract description 2
- 229960002433 cysteine Drugs 0.000 abstract description 2
- 235000018417 cysteine Nutrition 0.000 abstract description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract description 2
- 229960003067 cystine Drugs 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 229930182817 methionine Natural products 0.000 abstract description 2
- 229960004452 methionine Drugs 0.000 abstract description 2
- 229920000573 polyethylene Polymers 0.000 abstract description 2
- 239000005020 polyethylene terephthalate Substances 0.000 abstract description 2
- 229920001155 polypropylene Polymers 0.000 abstract description 2
- 239000002562 thickening agent Substances 0.000 abstract description 2
- 229940024606 amino acid Drugs 0.000 abstract 4
- 239000000243 solution Substances 0.000 abstract 3
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 abstract 1
- 239000011259 mixed solution Substances 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000012669 liquid formulation Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は経時的な着色を防止
したミノキシジル配合液剤組成物に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a minoxidil-containing liquid composition which prevents coloring over time.
【0002】[0002]
【従来の技術】ミノキシジルは、その育毛効果から外用
育毛剤として期待されている成分である。2. Description of the Related Art Minoxidil is a component which is expected as an externally used hair restorer due to its hair restorer effect.
【0003】しかし、ミノキシジルを溶液状態で保存す
ると経時的に着色しやすいという欠点があり、商品価値
の低下を招くことがあった。ミノキシジル配合液剤の着
色メカニズムには不明な点があるが、光が関与している
ものと推測される。そのためミノキシジル配合液剤を製
品化するためには遮光された容器を用いる必要がある
が、そのような容器では内容物の残量が明確にならない
など、使い勝手が悪いものであった。[0003] However, when minoxidil is stored in a solution state, it has a drawback that it is liable to be colored over time, which sometimes leads to a decrease in commercial value. Although the coloring mechanism of the minoxidil-containing liquid preparation has an unknown point, it is presumed that light is involved. Therefore, it is necessary to use a light-shielded container in order to commercialize the minoxidil-containing liquid product, but such a container is inconvenient because the remaining amount of the contents is not clear.
【0004】一般的に着色しやすい成分を液剤に配合す
るには、抗酸化剤やキレート防止剤などを配合して改善
させるが、ミノキシジル配合液剤の経時的な着色防止に
は十分な効果がなかった。[0004] In general, in order to incorporate a component which is easily colored into a liquid, the composition is improved by adding an antioxidant, an anti-chelating agent and the like. However, there is no sufficient effect on the prevention of coloring of the minoxidil-containing liquid over time. Was.
【0005】一方、製剤が着色しても目立たないように
最初から着色して製品とすることも考えられる。しか
し、育毛剤は頭皮に塗布して使用することから、最初か
ら着色しておくと衣類や寝具などを汚してしまう点から
好ましくない。On the other hand, it is also conceivable that the product is colored from the beginning so that the product is not noticeable even when colored. However, since the hair restorer is used after being applied to the scalp, it is not preferable to color the hair from the beginning since it stains clothes and bedding.
【0006】[0006]
【発明が解決しようとする課題】本発明はミノキシジル
を配合した液剤の着色を防止することを目的とする。SUMMARY OF THE INVENTION An object of the present invention is to prevent coloring of a liquid formulation containing minoxidil.
【0007】[0007]
【課題を解決するための手段】本発明者は上記課題を解
決するために種々検討した結果、ミノキシジルを配合し
た液剤にアミノ酸、特にタウリンを配合すると、驚くべ
きことに液剤の着色を防止することができることを見出
し本発明を完成した。Means for Solving the Problems The present inventors have conducted various studies to solve the above-mentioned problems. As a result, when amino acids, particularly taurine, are added to a liquid containing minoxidil, surprisingly, the coloring of the liquid can be prevented. It has been found that the present invention has been completed and the present invention has been completed.
【0008】すなわち本発明は、ミノキシジルおよびア
ミノ酸を含んでなる液剤組成物である。That is, the present invention is a liquid composition comprising minoxidil and an amino acid.
【0009】[0009]
【発明の実施の形態】本発明においてアミノ酸は育毛剤
に配合可能なものであれば使用することができ、塩も包
含する。BEST MODE FOR CARRYING OUT THE INVENTION In the present invention, any amino acid can be used as long as it can be blended with a hair restorer, including salts.
【0010】本発明ではアミノ酸のなかでも、着色防止
効果の点から含硫アミノ酸(タウリン、システイン、シ
スチン、メチオニン、ホモシステインなど)が好まし
く、その中でもタウリンが特に好ましい。In the present invention, among the amino acids, sulfur-containing amino acids (taurine, cysteine, cystine, methionine, homocysteine, etc.) are preferred from the viewpoint of the coloring prevention effect, and among them, taurine is particularly preferred.
【0011】本発明の液剤組成物においてミノキシジル
の濃度は液剤の0.1〜5重量%が好ましい。0.1重
量%未満であると育毛剤としてのミノキシジルの効力が
弱くなり、5重量%を越えると製剤設計が困難になるか
らである。In the liquid composition of the present invention, the concentration of minoxidil is preferably 0.1 to 5% by weight of the liquid preparation. If the amount is less than 0.1% by weight, the efficacy of minoxidil as a hair restorer will be weak, and if it exceeds 5% by weight, formulation design will be difficult.
【0012】本発明においては、アミノ酸の配合量が多
いほど液剤の着色防止効果の向上が見込めるが、ミノキ
シジル1重量部に対するアミノ酸の配合量は0.01〜
20重量部が好ましい。In the present invention, the higher the amount of the amino acid, the better the effect of preventing the coloring of the liquid preparation can be expected.
20 parts by weight are preferred.
【0013】本発明の液剤組成物では、液剤の溶媒は含
水系の有機溶媒が好ましい。有機溶媒のみであるとアミ
ノ酸が溶解せず、水のみであるとミノキシジルが溶解し
ないからである。このときの含水率は10〜50V/V%
が好ましい。ここで、用いる有機溶媒は水と均一に混合
し、さらに皮膚外用剤として使用しても皮膚に対して悪
影響を及ぼさない溶媒である必要がある。その点から、
有機溶媒としては炭素原子数1〜6のアルコール類(エ
タノール、プロパノール、イソプロパノール、エチレン
グリコール、プロピレングリコール、1,3-ブチレングリ
コール、グリセリンなど)が好ましく、その中でもエタ
ノール、プロピレングリコールおよび1,3-ブチレングリ
コールからなる群から選ばれる1種または2種以上が特
に好ましい。In the liquid composition of the present invention, the solvent of the liquid is preferably a water-containing organic solvent. This is because amino acids do not dissolve when only an organic solvent is used, and minoxidil does not dissolve when only water is used. The water content at this time is 10 to 50 V / V%
Is preferred. Here, the organic solvent to be used must be a solvent which is uniformly mixed with water and which does not adversely affect the skin even when used as an external preparation for skin. From that point,
As the organic solvent, alcohols having 1 to 6 carbon atoms (ethanol, propanol, isopropanol, ethylene glycol, propylene glycol, 1,3-butylene glycol, glycerin and the like) are preferable, and among them, ethanol, propylene glycol and 1,3- One or more selected from the group consisting of butylene glycol is particularly preferred.
【0014】本発明においては着色防止の点から、液剤
を精製水で20倍希釈したときのpHが4〜9のものが
好ましい。In the present invention, from the viewpoint of preventing coloration, those having a pH of 4 to 9 when the solution is diluted 20 times with purified water are preferred.
【0015】本発明によりミノキシジル配合液剤組成物
の保存容器は一般的な液剤に使用可能な容器であれば選
択することができる様になったが、PET、ガラス、ポ
リエチレン、ポリプロピレンなどの材質が特に好まし
い。According to the present invention, the storage container for the minoxidil-containing liquid composition can be selected as long as it can be used for general liquid preparations. However, materials such as PET, glass, polyethylene, and polypropylene are particularly preferable. preferable.
【0016】本発明の液剤の製造は、液剤製造の一般的
な方法により製造することができるが、アミノ酸を配合
する際に、先に水に溶解したものを有機溶媒に混合する
方法が好ましい。アミノ酸の溶解速度の点から含水有機
溶媒に後からアミノ酸を溶解させるのは時間がかかるか
らである。The liquid preparation of the present invention can be prepared by a general method for preparing a liquid preparation, but it is preferable to mix an amino acid previously dissolved in water with an organic solvent when compounding an amino acid. This is because it takes time to dissolve the amino acid in the water-containing organic solvent later from the viewpoint of the dissolution rate of the amino acid.
【0017】本発明によれば、アミノ酸による製剤の着
色防止効果が認められたが、さらにアミノ酸が有する薬
理作用(抗炎症作用、皮膚刺激低減作用、鎮痒作用な
ど)が発現されることも同時に期待できる。According to the present invention, although the coloring prevention effect of the preparation by the amino acid was recognized, it is also expected that the pharmacological action (anti-inflammatory action, skin irritation reducing action, antipruritic action, etc.) of the amino acid is exhibited. it can.
【0018】本発明の液剤は、外用液剤に一般的に使用
される成分(溶解補助剤、増粘剤、吸収促進剤、pH調
節剤など)を配合することができる。The liquid preparation of the present invention may contain components generally used in external preparations (dissolution aids, thickeners, absorption promoters, pH adjusters, etc.).
【0019】[0019]
【発明の効果】本発明により、ミノキシジル配合液剤の
着色を防止することが可能になった。According to the present invention, it is possible to prevent coloring of a liquid formulation containing minoxidil.
【0020】[0020]
【実施例】以下、実施例および試験例により本発明をさ
らに詳細に説明する。The present invention will be described in more detail with reference to the following Examples and Test Examples.
【0021】実施例1 ミノキシジル1g、タウリン0.04g、プロピレング
リコール10g、エタノール60gおよび全量100ml
とする量の精製水を撹拌溶解し液剤組成物を得た。Example 1 1 g of minoxidil, 0.04 g of taurine, 10 g of propylene glycol, 60 g of ethanol and a total amount of 100 ml
Of purified water was stirred and dissolved to obtain a liquid composition.
【0022】比較例1 実施例1の処方からタウリンを除いた処方で同様にして
比較用液剤を得た。Comparative Example 1 A comparative liquid preparation was obtained in the same manner as in Example 1 except that taurine was omitted.
【0023】試験例1 実施例1および比較例1の液剤を各3本ずつ透明ガラス
ビンに充填し、室温にて光量3000Luxの光を34日
間照射した。試験開始時および試験後の波長420nmの
吸光度を測定した結果を表1に示した。Test Example 1 Each of three liquid preparations of Example 1 and Comparative Example 1 was filled in a transparent glass bottle, and irradiated with light of 3000 Lux at room temperature for 34 days. The results of measuring the absorbance at a wavelength of 420 nm at the start of the test and after the test are shown in Table 1.
【0024】[0024]
【表1】 [Table 1]
【0025】実施例2 ミノキシジル1g、タウリン0.1g、プロピレングリ
コール10g、エタノール60gおよび精製水で全量を
100mlにする精製水を撹拌溶解して液剤を得た。Example 2 1 g of minoxidil, 0.1 g of taurine, 10 g of propylene glycol, 60 g of ethanol and purified water made up to 100 ml with purified water were stirred and dissolved to obtain a liquid preparation.
【0026】試験例2 実施例2の液剤組成物および比較例1の比較用液剤を、
それぞれ無色のガラス瓶に入れ、室内の光が射し込む窓
辺に室温で6ヶ月間放置した。30日後および6ヶ月後
に溶液の内容を知らない3名の測定者の目視により着色
の判定をした。また、試験開始時および6ヶ月後の42
0nmの吸光度を測定した。Test Example 2 The liquid composition of Example 2 and the comparative liquid of Comparative Example 1 were
Each was placed in a colorless glass bottle and left at room temperature for 6 months at a window illuminated by room light. After 30 days and 6 months, the color was judged visually by three measurers who did not know the contents of the solution. In addition, at the start of the test and after 6 months, 42
The absorbance at 0 nm was measured.
【0027】結果を表2に示した。The results are shown in Table 2.
【0028】[0028]
【表2】 [Table 2]
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI // A61K 7/06 A61K 7/06 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 6 Identification code FI // A61K 7/06 A61K 7/06
Claims (10)
液剤組成物。1. A liquid composition comprising minoxidil and an amino acid.
載の液剤組成物。2. The liquid composition according to claim 1, wherein the amino acid is a sulfur-containing amino acid.
液剤組成物。3. The liquid composition according to claim 1, wherein the amino acid is taurine.
の配合量が0.01〜20重量部である請求項1記載の
液剤組成物。4. The liquid composition according to claim 1, wherein the amount of the amino acid is 0.01 to 20 parts by weight per 1 part by weight of minoxidil.
アルコール類との混液である請求項1〜4のいずれかに
記載の液剤組成物。5. The liquid composition according to claim 1, wherein the solvent of the liquid is a mixture of water and an alcohol having 1 to 6 carbon atoms.
の混液中における水の含有率が10〜50V/V%であ
る、請求項5記載の液剤組成物。6. The liquid composition according to claim 5, wherein the content of water in a mixture of water and an alcohol having 1 to 6 carbon atoms is 10 to 50 V / V%.
ール、プロピレングリコールおよび1,3-ブチレングリコ
ールからなる群から選ばれる1種または2種以上である
請求項5記載の液剤組成物。7. The liquid composition according to claim 5, wherein the alcohol having 1 to 6 carbon atoms is one or more selected from the group consisting of ethanol, propylene glycol and 1,3-butylene glycol.
〜5重量%である請求項1〜7のいずれかに記載の液剤
組成物。8. The compounding amount of minoxidil is 0.1% of the whole preparation.
The liquid composition according to any one of claims 1 to 7, wherein the content is from 5 to 5% by weight.
合液剤の着色防止剤。9. An anti-coloring agent for a minoxidil-containing solution containing an amino acid as an active ingredient.
ノキシジル配合液剤の着色防止方法。10. A method for preventing coloring of a minoxidil-containing liquid preparation, which comprises mixing an amino acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10342699A JPH11263727A (en) | 1997-12-03 | 1998-12-02 | Minoxidil formulated liquid preparation composition |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP33306097 | 1997-12-03 | ||
JP9-333060 | 1997-12-03 | ||
JP10342699A JPH11263727A (en) | 1997-12-03 | 1998-12-02 | Minoxidil formulated liquid preparation composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11263727A true JPH11263727A (en) | 1999-09-28 |
Family
ID=26574382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10342699A Pending JPH11263727A (en) | 1997-12-03 | 1998-12-02 | Minoxidil formulated liquid preparation composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH11263727A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2002092092A1 (en) * | 2001-05-15 | 2004-10-21 | 大正製薬株式会社 | Minoxidil-containing liquid composition |
JP2018048105A (en) * | 2016-01-22 | 2018-03-29 | 大正製薬株式会社 | Composition for external use |
JP2018048123A (en) * | 2016-09-15 | 2018-03-29 | 大正製薬株式会社 | Composition for external use |
JP2018048104A (en) * | 2016-01-22 | 2018-03-29 | 大正製薬株式会社 | Composition for external use |
CN115501178A (en) * | 2022-08-26 | 2022-12-23 | 山东京卫制药有限公司 | Stable liquid composition containing minoxidil and preparation method thereof |
-
1998
- 1998-12-02 JP JP10342699A patent/JPH11263727A/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2002092092A1 (en) * | 2001-05-15 | 2004-10-21 | 大正製薬株式会社 | Minoxidil-containing liquid composition |
JP2018048105A (en) * | 2016-01-22 | 2018-03-29 | 大正製薬株式会社 | Composition for external use |
JP2018048104A (en) * | 2016-01-22 | 2018-03-29 | 大正製薬株式会社 | Composition for external use |
JP2018162319A (en) * | 2016-01-22 | 2018-10-18 | 大正製薬株式会社 | Composition for external use |
JP2018162320A (en) * | 2016-01-22 | 2018-10-18 | 大正製薬株式会社 | Composition for external use |
JP2018048123A (en) * | 2016-09-15 | 2018-03-29 | 大正製薬株式会社 | Composition for external use |
JP2021165305A (en) * | 2016-09-15 | 2021-10-14 | 大正製薬株式会社 | Composition for external use |
CN115501178A (en) * | 2022-08-26 | 2022-12-23 | 山东京卫制药有限公司 | Stable liquid composition containing minoxidil and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4264581A (en) | Sunscreen composition | |
JP4390030B2 (en) | Minoxidil combination liquid composition | |
RU2140255C1 (en) | Pure antiperspirant stick | |
JP2002532401A (en) | Hydrophobically modified polysaccharides in anhydrous antiperspirant products | |
JPH11263727A (en) | Minoxidil formulated liquid preparation composition | |
EP0010437B1 (en) | Stable erythromycin solution and process therefor | |
JP4189223B2 (en) | Minoxidil combination liquid composition | |
JP4796260B2 (en) | Minoxidil-containing preparation | |
EP0016533B1 (en) | Anti-perspirant compositions | |
JP4442912B2 (en) | Composition for external use | |
RU2212228C2 (en) | Cosmetic composition causing weak skin irritation | |
MXPA00005424A (en) | Minoxidil-containing liquid preparation composition | |
JP2004155733A (en) | Cosmetic | |
JP2769341B2 (en) | Stable external base composition | |
JPH0558845A (en) | Aerosol composition for hair | |
JP2000281555A (en) | Skin preparation for external use | |
JP2023099672A (en) | External pharmaceutical composition | |
JPS6296404A (en) | Beautifying cosmetic | |
JP2004155735A (en) | Basic cosmetic | |
JPH11246373A (en) | Depilatory | |
JP2020172482A (en) | External pharmaceutical composition | |
JPS5927324B2 (en) | Gargle composition | |
JPH0867612A (en) | Composition for hair | |
JPH0640855A (en) | Hair dressing | |
JPH0656635A (en) | Aerosol composition for hair |